Stay Alert for Patients Stopping Dopamine Agonists

August 2021

Health Canada is warning about the risk of withdrawal symptoms when stopping dopamine agonists (pramipexole, ropinirole, etc).

These meds are often used for Parkinson's disease, restless legs syndrome, or other conditions.

But some patients who stop or reduce the dose of these meds experience "dopamine agonist withdrawal syndrome" (DAWS).

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter Canada includes:

12 issues every year, with brief articles about new meds and hot topics
120+ CE courses, including the popular CE-in-the-Letter
Helpful, in-depth Technician Tutorials
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

Med Administration Take Care With Meds That Should Be Given Together
COVID-19 Be Familiar With the Latest Monoclonal Antibody to Treat COVID-19
Infectious Diseases Prevent Mishaps When Dispensing Meds for C. diff Diarrhea
Topicals Help Patients Asking About Water Exposure and Topical or Transdermal Meds
Natural Medicines Listen for Patients Reporting Heart Rhythm Problems With Ginkgo
Communication Don't Shy Away From Communicating Concerns to Colleagues
Adverse Events Stay Alert for Patients Stopping Dopamine Agonists
Rheumatoid Arthritis Avoid Mix-Ups With Rheumatoid Arthritis Meds
Colon Cancer Sort Through Colon Cancer Screening Options